CPHI & PMEC China 2026
06/2026 – 06/2026
회사 소개
- 법인명: ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD.
- 등록 국가: China
- 주소: No.800, Dadao East Road,Chengguan, Zhejiang
- 설립 연도: 1990
설명:
Jingxin Pharm is a producer of APIs such as Simvastatin, Levofloxacin Hemihydrate, Ciprofloxacin HCl, Gatifloxacin, and Enrofloxacin Base and HCl, as well as finished dosage forms such as tablets, capsules and injections. Jingxin Pharm holds EDMF and US DMF filings for all products, and its formulation factory has received German GMP approval.
사업 활동
완제 의약품
제조업체
부형제 & 첨가제
제조업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Iceland
당사 제품 & 서비스
증거
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기